Skip to content

Clinical trials

Phase 1/2 Lung Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 1/2 Clear all

300 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20014
20025
200310
20047
20056
20069
200710
200814
200910
20109
20114
20126
20133
201410
201517
201611
201717
201815
201913
202013
202120
202211
202320
202414
202514
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed120
Recruiting55
Terminated51
Active, not recruiting24
Unknown status24
Withdrawn18
Not yet recruiting6
Suspended2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center17
National Cancer Institute (NCI)12
Fuda Cancer Hospital, Guangzhou9
Memorial Sloan Kettering Cancer Center9
H. Lee Moffitt Cancer Center and Research Institute5
Incyte Corporation5
University of California, Davis5
Massachusetts General Hospital4
Radiation Therapy Oncology Group4
Revolution Medicines, Inc.4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms300
Carcinoma, Non-Small-Cell Lung158
Breast Neoplasms42
Colorectal Neoplasms40
Neoplasms39
Neoplasm Metastasis38
Pancreatic Neoplasms33
Ovarian Neoplasms32
Head and Neck Neoplasms29
Melanoma26

Trials

Showing 51 to 75 of 300. Each trial links to its page on Pharma Observatory.

200 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.